![Marlene Gyldmark](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Marlene Gyldmark
Director/Board Member at International Society for Pharmacoeconomics & Outcomes Rsch
Marlene Gyldmark active positions
Companies | Position | Start | End |
---|---|---|---|
International Society for Pharmacoeconomics & Outcomes Rsch
![]() International Society for Pharmacoeconomics & Outcomes Rsch Miscellaneous Commercial ServicesCommercial Services International Society for Pharmacoeconomics & Outcomes Research provides health care researches. The organization have health care researchers from all disciplines conducting health care outcomes research. These disciplines include pharmacoeconomics (health economics), epidemiology (pharmacoepidemiology), decision analysis, modeling, risk assessment, patient-reported outcomes (quality of life), use of ‘real world’ data such as health care database analyses, observational studies, patient registries. | Director/Board Member | - | - |
Career history of Marlene Gyldmark
Training of Marlene Gyldmark
University of Copenhagen | Graduate Degree |
York University | Graduate Degree |
Statistics
International
United States | 2 |
Denmark | 2 |
Canada | 2 |
Operational
Graduate Degree | 2 |
Director/Board Member | 1 |
Sectoral
Consumer Services | 3 |
Commercial Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 1 |
---|---|
International Society for Pharmacoeconomics & Outcomes Rsch
![]() International Society for Pharmacoeconomics & Outcomes Rsch Miscellaneous Commercial ServicesCommercial Services International Society for Pharmacoeconomics & Outcomes Research provides health care researches. The organization have health care researchers from all disciplines conducting health care outcomes research. These disciplines include pharmacoeconomics (health economics), epidemiology (pharmacoepidemiology), decision analysis, modeling, risk assessment, patient-reported outcomes (quality of life), use of ‘real world’ data such as health care database analyses, observational studies, patient registries. | Commercial Services |
- Stock Market
- Insiders
- Marlene Gyldmark
- Experience